These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12453828)

  • 21. Twenty-four-hour secretory patterns of growth hormone, prolactin, and cortisol in narcolepsy.
    Higuchi T; Takahashi Y; Takahashi K; Niimi Y; Miyasita A
    J Clin Endocrinol Metab; 1979 Aug; 49(2):197-204. PubMed ID: 457840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1).
    Baier PC; Weinhold SL; Huth V; Gottwald B; Ferstl R; Hinze-Selch D
    Brain; 2008 Oct; 131(Pt 10):2734-41. PubMed ID: 18718966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian rhythm in salivary melatonin in narcoleptic patients.
    Blazejova K; Illnerova H; Hajek I; Nevsimalova S
    Neurosci Lett; 2008 May; 437(2):162-4. PubMed ID: 18436380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Nacrolepsy manifesting initially as cataplexy and sleep paralysis: usefulness of CSF hypocretin-1 examination for early diagnosis].
    Kobayashi Y; Miyamoto M; Miyamoto T; Yamazaki K; Hirata K; Kanbayashi T; Shimizu T
    Rinsho Shinkeigaku; 2002 Mar; 42(3):233-6. PubMed ID: 12474294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss.
    Rasmussen MH; Wildschiødtz G; Juul A; Hilsted J
    Obesity (Silver Spring); 2008 Jul; 16(7):1516-21. PubMed ID: 18464752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous GH-releasing hormone increases GH and LH secretion in growing mithuns (Bos frontalis).
    Mondal M; Rajkhowa C; Prakash BS
    Gen Comp Endocrinol; 2006 Nov; 149(2):197-204. PubMed ID: 16843461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced hypothalamic gray matter in narcolepsy with cataplexy.
    Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S
    Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men.
    Koutkia P; Canavan B; Breu J; Johnson ML; Grinspoon SK
    Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E506-12. PubMed ID: 15138154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of long-term growth hormone-releasing factor administration on plasma growth hormone, luteinizing hormone and progesterone profiles in growing female buffaloes (Bubalus bubalis).
    Mondal M; Prakash BS
    Reprod Domest Anim; 2004 Oct; 39(5):333-9. PubMed ID: 15367266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 24-h growth hormone rhythm in men: sleep and circadian influences questioned.
    Brandenberger G; Weibel L
    J Sleep Res; 2004 Sep; 13(3):251-5. PubMed ID: 15339260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orexin-A regulates growth hormone-releasing hormone mRNA content in a nucleus-specific manner and somatostatin mRNA content in a growth hormone-dependent fashion in the rat hypothalamus.
    López M; Seoane LM; Tovar S; Nogueiras R; Diéguez C; Señarís R
    Eur J Neurosci; 2004 Apr; 19(8):2080-8. PubMed ID: 15090035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal cerebrospinal fluid levels of hypocretin-1 (orexin A) in patients with fibromyalgia syndrome.
    Taiwo OB; Russell IJ; Mignot E; Lin L; Michalek JE; Haynes W; Xiao Y; Zeitzer JM; Larson AA
    Sleep Med; 2007 Apr; 8(3):260-5. PubMed ID: 17369087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth Hormone Deficiency and Excessive Sleepiness: A Case Report and Review of the Literature.
    Gohil A; Eugster E
    Pediatr Endocrinol Rev; 2019 Sep; 17(1):41-46. PubMed ID: 31599135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index.
    van Aken MO; Pereira AM; Frölich M; Romijn JA; Pijl H; Veldhuis JD; Roelfsema F
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E63-70. PubMed ID: 15328071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orexin-B modulates luteinizing hormone and growth hormone secretion from porcine pituitary cells in culture.
    Barb CR; Matteri RL
    Domest Anim Endocrinol; 2005 Apr; 28(3):331-7. PubMed ID: 15760673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of long-term GH-releasing factor administration on patterns of GH and LH secretion in growing female buffaloes (Bubalus bubalis).
    Mondal M; Prakash BS
    Reproduction; 2004 Jan; 127(1):45-55. PubMed ID: 15056769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the cytokine and endocrine involvement in narcolepsy.
    Okun ML; Giese S; Lin L; Einen M; Mignot E; Coussons-Read ME
    Brain Behav Immun; 2004 Jul; 18(4):326-32. PubMed ID: 15157949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy.
    Schuld A; Blum WF; Pollmächer T
    Ann Neurol; 2002 May; 51(5):660; author reply 660-1. PubMed ID: 12112120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.